Indication, Unlabeled Clinical Trial
— Eval-4DFlowOfficial title:
Clinical Evaluation of 4D Flow Cardiac MRI Sequences - A Prospective Exploratory Study
| Verified date | June 2019 |
| Source | University Children's Hospital, Zurich |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
Assess the accuracy of 4D flow cardiac MRI to measure blood flow and velocity, delineate 3D cardiac anatomy and visualize flow dynamics using two (2) different pulse sequences.
| Status | Completed |
| Enrollment | 8 |
| Est. completion date | September 30, 2018 |
| Est. primary completion date | September 30, 2018 |
| Accepts healthy volunteers | Accepts Healthy Volunteers |
| Gender | All |
| Age group | N/A and older |
| Eligibility |
Inclusion Criteria Patients: - Clinical referral for cMRI in the absence of any contraindication to cMRI - Flow measurements are part of the clinical cMRI protocol - Signed informed consent of participants and/or legal representatives according to current ethical rules and regulations for children and adults - For females in reproductive age, exclusion of pregnancy by a pregnancy test conducted before the cMRI Exclusion Criteria Patients: - Any contraindication for undergoing a cMRI examination or for receiving gadolinium contrast media (renal failure, allergy) per internal institutional policy of University Children's Hospital Zurich - Any intrathoracic device causing imaging artifacts - Medical condition at time of examination that would make additional study-related MR scans an unjustified burden or risk. - Inability or unwillingness to provide informed consent. Inclusion Criteria Healthy Controls: - Absence of any contraindication to cMRI - Signed informed consent of participants according to current ethical rules and regulations - For females in reproductive age, exclusion of pregnancy by a pregnancy test conducted before the cMRI. Exclusion Criteria Healthy Controls: - Any contraindication for undergoing a cMRI examination per internal institutional policy of University Children's Hospital Zurich |
| Country | Name | City | State |
|---|---|---|---|
| n/a | |||
| Lead Sponsor | Collaborator |
|---|---|
| Emanuela Valsangiacomo |
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Feasibility of data processing | Comparison of flow velocities and blood flow measured by 4D flow cMRI pulse sequences against phantom corrected 2D cMRI data. | Within 72 hours after completion of exam | |
| Secondary | Image quality | Qualitative grading of 4D flow cMRI anatomical images for image quality using a numerical scale. | Within 72 hours after completion of exam | |
| Secondary | Comparability | Qualitative grading of comparability of anatomical findings in 4D flow cMRI anatomical images with contrast-enhanced MR angiography images, if these have been acquired during the clinical examination of patients, using a numerical scale. | Within 72 hours after completion of exam | |
| Secondary | Clinical value | Qualitative grading of clinical and diagnostic value of visualizations of flow dynamics using a numerical scale. | Within 72 hours after completion of exam |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05429060 -
A Prospective Evaluation of Hemorrhoidal Surgery Outcome in Istanbul
|
||
| Recruiting |
NCT05995925 -
Observational Study for Perioperative Care of Patients Requiring ICU (OPICU)
|